Advanced Enzyme Technologies Q2 net profit at Rs. 224mn


Advanced Enzyme Technologies Limited, a leading specialty biotech company, with global leadership in the manufacturing of enzymes, announced unaudited financial results for second quarter ended September 2017.

Financial Highlights – Q2FY18 vs Q2FY17:
Consolidated Q2FY18 Sales (net of excise duty) up 9% YoY to INR 986 mn against Rs. 904 mn in Q2FY17

Consolidated EBITDA for Q2FY18 stands at Rs. 414 mn against Rs. 487 mn in Q2FY17, down 15%

Consolidated EBITDA Margin for Q2FY18 stands at 42% as against 52% in Q2FY17

Consolidated Q2FY18 Net Profit down 23% at Rs. 224 mn against Rs. 291 in Q2FY17

NewsBarons is now active on WhatsApp. To receive news and updates on your handset, please click here and press send to subscribe.

Yash Ved
Yash Ved is a Senior Correspondent at NewsBarons and comes with a decade of experience across leading online and offline publications. A keen observer of the stock index movement, Yash also likes covering Real Estate and the BFSI sector. A financial management and Journalism student, Yash believes learning as a continuous journey and enjoys following the IT and the Pharmaceutical industry and has penned many articles on the subjects.